Market Overview: The global market size for surgical sealants adhesives was USD 1.82 Billion in 2022 and is projected to reach USD 2.59 Billion by 2032, with a rapid revenue Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period.

Market Growth Drivers: The rise in market revenue is predominantly driven by an uptick in surgical procedures and the prevalence of chronic illnesses. The increased demand for adhesive surgical sealants is a direct response to the growing necessity to prevent post-operative complications and ensure effective wound closure. These adhesives are essential in halting bleeding, sealing wounds, and enhancing overall patient outcomes.

Get a sample copy of the Surgical Sealants Adhesive Market report: https://www.reportsanddata.com/download-free-sample/2068

Market Growth Drivers:

1.      The popularity of minimally invasive procedures and advancements in surgical techniques.

2.      Increasing elderly population and prevalence of chronic diseases, including cancer and cardiovascular disorders.

3.      Emphasis on developing cutting-edge surgical sealants and adhesives, including biodegradable and bio-based options.

Market Challenges:

1.      High cost of surgical sealants and adhesives.

2.      Stringent regulatory requirements for approval.

3.      Availability of alternative wound closure solutions, such as sutures and staples.

Government Regulations: Regulatory bodies like the U.S. FDA, European Medical Device Regulation (MDR), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA) oversee the approval and use of surgical sealants and adhesives. Other countries also have specific regulations to ensure product safety and effectiveness.

Key Product Insights: The market is categorized into natural, synthetic, and hybrid sealants and adhesives. Natural products, with biocompatibility and potent wound closure capabilities, are expected to dominate. Synthetic options are growing at the fastest rate due to their adaptability and high-strength bonding abilities. Hybrid products, combining natural and synthetic components, are experiencing rapid expansion.

Application Insights: The market is segmented into cardiovascular, orthopedic, pulmonary, neurology, and other applications. Cardiovascular applications accounted for a significant share in 2022, driven by the global increase in cardiovascular disorders. Orthopedic applications are anticipated to have the fastest growth, propelled by the rising prevalence of orthopedic conditions and procedures.

Regional Market Outlook: North America is expected to have the quickest revenue CAGR, driven by energy-saving policies, increasing surgical operations, and a high prevalence of chronic illnesses. The Asia Pacific market is also poised for substantial growth, particularly in emerging nations like China and India. Europe is expected to experience modest growth, driven by an increase in surgical procedures in the food and beverage industries.

Competitive Landscape: Key players in the global Surgical Sealants Adhesive Market include Johnson & Johnson Services, Inc., Baxter International Inc., B. Braun Melsungen AG, CryoLife, Inc., Cohera Medical, Inc., C.R. Bard, Inc., Ocular Therapeutix, Inc., Sanofi S.A., Integra LifeSciences Corporation, and Sealantis Ltd.

Strategic Developments:

1.      Johnson & Johnson Services, Inc. launched VISTASEAL in 2021, a surgical sealant product for better hemostasis control.

2.      Baxter International Inc. partnered with Cohera Medical, Inc. in 2020 to distribute TissuGlu Surgical Adhesive in the United States and Canada.

3.      Integra LifeSciences Corporation acquired ACell, Inc. in 2020 to strengthen its position in the regenerative medicine and surgical sealant adhesive market.

New Product Launches:

1.      CryoLife, Inc. introduced BioFoam Surgical Matrix in 2021, a polyurethane-based surgical sealant.

2.      Ocular Therapeutix, Inc. launched ReSure Sealant in 2020, a hydrogel-based surgical adhesive.

3.      Sanofi S.A. introduced Quixil Surgical Sealant in 2020, a fibrin sealant for improved hemostasis.

Report Scope:

  • Market Size in 2022: USD 1.82 Billion
  • CAGR (2022-2032): 8.5%
  • Revenue Forecast in 2032: USD 2.59 Billion
  • Segmentation: By Product Type (Natural, Synthetic, Hybrid), By Application (Cardiovascular, Orthopedic, Pulmonary, Neurology, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
  • Key Companies: Johnson & Johnson Services Inc, Baxter International Inc, B. Braun Melsungen AG, CryoLife Inc, Cohera Medical Inc, C.R. Bard Inc, Ocular Therapeutix Inc, Sanofi S.A, Integra LifeSciences Corporation, Sealantis Ltd.

 

Explore Trending Reports:

Infection Control Market-https://www.reportsanddata.com/report-detail/global-infection-control-market

Bio-Aromatic Polyester Polyols Market-https://www.reportsanddata.com/report-detail/bio-aromatic-polyester-polyols-market

Humic Acid Market-https://www.reportsanddata.com/report-detail/humic-acid-market

Impregnating Resins Market-https://www.reportsanddata.com/report-detail/impregnating-resins-market

Logistics Automation Market-https://www.reportsanddata.com/report-detail/logistics-automation-market

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2068

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release